Skip to main content
SpringerLink
Log in

Transcriptome and Proteome Analyses of TNFAIP8 Knockdown Cancer Cells Reveal New Insights into Molecular Determinants of Cell Survival and Tumor Progression

  • Protocol
  • First Online:
Cancer Gene Networks

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1513))

Abstract

Tumor necrosis factor-α-inducible protein 8 (TNFAIP8) is the first discovered oncogenic and an anti-apoptotic member of a conserved TNFAIP8 or TIPE family of proteins. TNFAIP8 mRNA is induced by NF-kB, and overexpression of TNFAIP8 has been correlated with poor prognosis in many cancers. Downregulation of TNFAIP8 expression has been associated with decreased pulmonary colonization of human tumor cells, and enhanced sensitivities of tumor xenografts to radiation and docetaxel. Here we have investigated the effects of depletion of TNFAIP8 on the mRNA, microRNA and protein expression profiles in prostate and breast cancers and melanoma. Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1. TNFAIP8 knockdown cells also exhibited decreased expression of multiple onco-proteins (e.g., PIK3CA, SRC, EGFR, IL5, ABL1, GAP43), and increased expression of the orphan nuclear receptor NR4A1 and alpha 1 adaptin subunit of the adaptor-related protein complex 2 AP2 critical to clathrin-mediated endocytosis. TNFAIP8-centric molecules were found to be predominately implicated in the hypoxia-inducible factor-1α (HIF-1α) signaling pathway, and cancer and development signaling networks. Thus TNFAIP8 seems to regulate the cell survival and cancer progression processes in a multifaceted manner. Future validation of the molecules identified in this study is likely to lead to new subset of molecules and functional determinants of cancer cell survival and progression.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Patel S, Wang FH, Whiteside TL, Kasid U (1997) Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response. Oral Oncol 33:197–203

    Article  CAS  PubMed  Google Scholar 

  2. Kumar D, Whiteside TL, Kasid U (2000) Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin- 1beta-converting enzyme-inhibitory protein. J Biol Chem 275:2973–2978

    Article  CAS  PubMed  Google Scholar 

  3. Zhang Z, Liang X, Gao L et al (2015) TIPE1 induces apoptosis by negatively regulating Rac1 activation in hepatocellular carcinoma cells. Oncogene 34:2566–2574

    Article  CAS  PubMed  Google Scholar 

  4. Sun H, Gong S, Carmody RJ et al (2008) TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 133:415–426

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Gus-Brautbar Y, Johnson D, Zhang L et al (2012) The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras. Mol Cell 45:610–618

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Fayngerts SA, Wu J, Oxley CL et al (2014) TIPE3 is the transfer protein of lipid second messengers that promote cancer. Cancer Cell 26:465–478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Lou Y, Liu S (2011) The TIPE (TNFAIP8) family in inflammation, immunity, and cancer. Mol Immunol 49:4–7

    Article  CAS  PubMed  Google Scholar 

  8. Zhang X, Wang J, Fan C et al (2009) Crystal structure of TIPE2 provides insights into immune homeostasis. Nat Struct Mol Biol 16:89–90

    Article  CAS  PubMed  Google Scholar 

  9. Horrevoets AJ, Fontijn RD, van Zonneveld AJ et al (1999) Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes. Blood 93:3418–3431

    CAS  PubMed  Google Scholar 

  10. You Z, Ouyang H, Lopatin D et al (2001) Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem 276:26398–26404

    Article  CAS  PubMed  Google Scholar 

  11. Kumar D, Gokhale P, Broustas C et al (2004) Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene 23:612–616

    Article  CAS  PubMed  Google Scholar 

  12. Zhang C, Chakravarty D, Sakabe I et al (2006) Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther 13:947–955

    Article  CAS  PubMed  Google Scholar 

  13. Zhang C, Kallakury BV, Ross JS et al (2013) The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence. Int J Cancer 133:31–42

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Day TF (2015) Effects of TNFAIP8 knockdown on EGFR and IGF-1R signaling and cytotoxicities of targeted drugs in non-small cell lung cancer cells. Ph.D. Dissertation submitted to the Faculty of the Graduate School of Arts and Sciences of Georgetown University

    Google Scholar 

  15. Zhang LJ, Liu X, Gafken PR et al (2009) A chicken ovalbumin upstream promoter transcription factor I (COUP-TFI) complex represses expression of the gene encoding tumor necrosis factor alpha-induced protein 8 (TNFAIP8). J Biol Chem 284:6156–6168

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wang Y, Hayakawa J, Long F et al (2005) “Promoter array” studies identify cohorts of genes directly regulated by methylation, copy number change, or transcription factor binding in human cancer cells. Ann N Y Acad Sci 1058:162–185

    Article  CAS  PubMed  Google Scholar 

  17. Chakravarty D (2007) Role of SCC-S2 in breast cancer cell proliferation and invasion. Ph.D. Dissertation submitted to the Faculty of the Graduate School of Arts and Sciences of Georgetown University

    Google Scholar 

  18. Dong QZ, Zhao Y, Liu Y et al (2010) Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung cancer. Cancer Sci 101:1562–1569

    Article  CAS  PubMed  Google Scholar 

  19. Liu K, Qin CK, Wang ZY et al (2012) Expression of tumor necrosis factor-alpha-induced protein 8 in pancreas tissues and its correlation with epithelial growth factor receptor levels. Asian Pac J Cancer Prev 13:847–850

    Article  PubMed  Google Scholar 

  20. Duan D, Zhu YQ, Guan LL et al (2014) Upregulation of SCC-S2 in immune cells and tumor tissues of papillary thyroid carcinoma. Tumour Biol 35:4331–4337

    Article  CAS  PubMed  Google Scholar 

  21. Eisele L, Klein-Hitpass L, Chatzimanolis N et al (2007) Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia. Acta Haematol 117:8–15

    Article  CAS  PubMed  Google Scholar 

  22. Laliberté B, Wilson AM, Nafisi H et al (2010) TNFAIP8: a new effector for Galpha(i) coupling to reduce cell death and induce cell transformation. J Cell Physiol 225:865–874

    Article  PubMed  PubMed Central  Google Scholar 

  23. Srivastava M, Eidelman O, Jozwik C et al (2006) Serum proteomic signature for cystic fibrosis using an antibody microarray platform. Mol Genet Metab 87:303–310

    Article  CAS  PubMed  Google Scholar 

  24. Jozwik CE, Pollard HB, Srivastava M et al (2012) Antibody microarrays: analysis of cystic fibrosis. Methods Mol Biol 23:179–200

    Article  Google Scholar 

  25. Huang D, Li T, Li X et al (2014) HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression. Cell Rep 8:1930–1942

    Article  CAS  PubMed  Google Scholar 

  26. Vinciguerra M, Sgroi A, Veyrat-Durebex C et al (2009) Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 upregulation in hepatocytes. Hepatology 49:1176–1184

    Article  CAS  PubMed  Google Scholar 

  27. Hu H, Takano N, Xiang L et al (2014) Hypoxia-inducible factors enhance glutamate signaling in cancer cells. Oncotarget 5:8853–8868

    Article  PubMed  PubMed Central  Google Scholar 

  28. Liu ZG, Smith SW, McLaughlin KA et al (1994) Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367:281–284

    Article  CAS  PubMed  Google Scholar 

  29. Lin B, Kolluri SK, Lin F et al (2004) Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116:527–540

    Article  CAS  PubMed  Google Scholar 

  30. Mullican SE, Zhang S, Konopleva M et al (2007) Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat Med 13:730–735

    Article  CAS  PubMed  Google Scholar 

  31. Zhou F, Drabsch Y, Dekker TJA et al (2014) Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signaling. Nat Commun 5:3388. doi:10.1038/ncomms4388

    PubMed  Google Scholar 

  32. Wenzl K, Troppan K, Neumeister P, Deutsch AJ (2015) The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. Curr Drug Targets 16:38–46

    Article  CAS  PubMed  Google Scholar 

  33. Hanna RN, Cekic C, Sag D et al (2015) Patrolling monocytes control tumor metastasis to the lung. Science 350:985–990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Höning S, Ricotta D, Krauss M et al (2005) Phosphatidylinositol-(4,5)-bisphosphate regulates sorting signal recognition by the clathrin-associated adaptor complex AP2. Mol Cell 18:519–531

    Article  PubMed  Google Scholar 

  35. Traub LM (2009) Tickets to ride: selecting cargo for clathrin-regulated internalization. Nat Rev Mol Cell Biol 10:583–596

    Article  CAS  PubMed  Google Scholar 

  36. McMahon HT, Boucrot E (2011) Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 12:517–533

    Article  CAS  PubMed  Google Scholar 

  37. Kelly BT, Graham SC, Liska N et al (2014) AP2 controls clathrin polymerization with a membrane-activated switch. Science 345:459–463

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Tong J, Taylor P, Moran MF (2014) Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress. Mol Cell Proteomics 13:1644–1658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Shevde LA, Samant RS, Paik JC et al (2006) Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435. Clin Exp Metastasis 23:123–133

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Timothy F. Day, Rajshree R. Mewani, and Joshua Starr contributed equally to this work. This work was supported by grants from the National Institutes of Health (CA68322, CA74175) and Department of Defense (PC074171). TFD was supported, in part, by predoctoral fellowship award from the Department of Defense (W81XWH-10-1-0107). LM2-4175 cells were a gift from Dr. Joan Massagué. Portions of the work presented in this chapter were carried out by TFD and DC toward their Ph.D. dissertations. UNK is a coinventor on patent application, “Anti-apoptotic gene SCC-S2 and diagnostic and therapeutic uses thereof,” (US 12/858,360). Several cell lines were obtained from the Tissue Culture Shared Resource of the Georgetown Lombardi Comprehensive Cancer Center. The RNA array and microRNA array studies were performed using the Genomics and Epigenomics Shared Resource of the Georgetown Lombardi Comprehensive Cancer Center. All shared resources were supported by the NIH Grant P30-CA51008.

Author information

Authors and Affiliations

  1. Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Rd, NW, Washington, DC, 20057, USA

    Timothy F. Day, Rajshree R. Mewani, Xin Li, Debyani Chakravarty, Habtom Ressom, Xiaojun Zou & Usha N. Kasid

  2. Department of Anatomy, Physiology and Genetics, Institute for Molecular Medicine, Center for Medical Proteomics, Uniformed Services University School of Medicine, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA

    Joshua Starr, Ofer Eidelman, Harvey B. Pollard & Meera Srivastava

Authors
  1. Timothy F. Day
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rajshree R. Mewani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joshua Starr
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Debyani Chakravarty
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Habtom Ressom
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaojun Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ofer Eidelman
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Harvey B. Pollard
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Meera Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Usha N. Kasid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Usha N. Kasid .

Editor information

Editors and Affiliations

  1. Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA

    Usha Kasid

  2. Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA

    Robert Clarke

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this protocol

Cite this protocol

Day, T.F. et al. (2017). Transcriptome and Proteome Analyses of TNFAIP8 Knockdown Cancer Cells Reveal New Insights into Molecular Determinants of Cell Survival and Tumor Progression. In: Kasid, U., Clarke, R. (eds) Cancer Gene Networks. Methods in Molecular Biology, vol 1513. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6539-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6539-7_7

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6537-3

  • Online ISBN: 978-1-4939-6539-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation